October Influenza Testing for the Season. Lauren Anthony, MD, MT(ASCP)SBB Medical Director, Allina Medical Laboratories
|
|
- Elisabeth Byrd
- 6 years ago
- Views:
Transcription
1 October 2010 Lauren Anthony, MD, MT(ASCP)SBB Medical Director, Allina Medical Laboratories Influenza Testing for the Season This Year s Influenza Virus: Sporadic cases of seasonal influenza A (H3N2) were confirmed by the Minnesota Department of Health (MDH) during September and October and all Minnesota cases to date have been caused by the seasonal strain, H3N2. Nationwide, the majority of flu cases this fall have been due to seasonal strains, not H1N1. Influenza Prevalence As of late October, influenza prevalence in Minnesota has been very low (<2.5%). Most of the respiratory viruses circulating have been identified as rhinovirus, adenovirus, coronavirus, and parainfluenza. Vaccine Coverage This year s vaccine provides good coverage of the circulating influenza A and B strains identified to date. The circulating seasonal strain, H3N2/A/ Perth/16/2009, is covered by this years vaccine, but was not in last year s vaccine. This year s vaccine also covers 2009 H1N1 and the currently circulating influenza B strain, B/Brisbane/60/2008. Note: Patients who receive the live nasal influenza vaccine (FluMist) can have positive results for all flu tests (rapid antigen, PCR, culture) for 4 days or more after vaccination. This does not occur with the inactivated injectable flu vaccine. Rapid Influenza Antigen Testing Rapid influenza antigen testing was suspended during the H1N1 outbreak last year due to the inability of available rapid tests to detect this strain. Now that seasonal flu strains dominate, rapid influenza testing has resumed. It is important to understand the limitations of rapid tests when interpreting results.
2 The positive and negative predictive values of rapid flu antigen testing depend upon the prevalence of influenza in the population (See Table 1). This means that: There is a high false positive rate, up to 50%, when flu prevalence is low. Negative rapid flu test results do not exclude influenza. Table 1. The positive and negative predictive values of rapid flu testing depend upon the prevalence of flu in the population. If Flu Prevalence And Specificity Then PPV is False Pos. rate is is is VERY LOW (2.5%) GOOD (98%) POOR (39-56%) HIGH (44-61%) MODERATE (20%) GOOD (98%) GOOD (86-93%) LOW (7-14%) If Flu Prevalence And Sensitivity Then NPV is False Neg. rate is is is MODERATE (20%) HIGH (90%) V. GOOD (97-99%) V. LOW (2-3%) HIGH (40%) HIGH (90%) V. GOOD (93-94%) LOW (6-7%) To learn more about predictive values: MiniModules/Predictive_Values/page01.htm Specimens For Rapid Flu Testing The real-world sensitivity of rapid flu testing is highly dependent on specimen quality. Poor specimen collection is a major cause of rapid flu false negatives. Although influenza infection produces copious amounts of nasal mucus, the actual virus is localized and concentrated in the ciliated columnar epithelium of the posterior nasopharynx, not the squamous lining of the nares or in the mucus discharge. Nasopharyngeal specimens (NP swabs/aspirates/washes) give the best results and are always acceptable. Nasal swabs may be acceptable, depending on the test used, but generally have a lower detection rate, especially in adults. See Table 2. 2
3 Table 2: Rapid flu testing Acceptable Specimens Depend Upon the Laboratory Site and Rapid Flu Test Used Allina Hospitals Directigen Flu A/B Preferred: Nasopharyngeal Minitip Culture swab in Bacti Culturette or viral transport medium. Alternate specimens: Nasopharyngeal aspirate or wash in sterile container. Nasal swabs are not acceptable for this test method. Allina Clinics (AMC, Aspen, Quello) QuickVue Flu A/B Preferred: Nasopharyngeal Minitip Culture swab in Bacti Culturette or viral transport medium. Alternate specimens: Nasopharyngeal aspirate or wash in sterile container. Nasal swabs acceptable if collected using a QuickVue foam swab obtained from the laboratory. Detection rates may be lower with nasal specimens. Non-Allina Sites Contact the specific laboratory for specimen requirements and collection devices. H1N1 Testing No Longer Orderable H1N1 testing is not indicated because the circulating influenza A strains are mostly seasonal H3N2. The Minnesota Department of Health identifies and tracks circulating flu strains through a very robust statewide surveillance system, and will keep laboratories and providers informed of any changes in circulating strains and strategies for testing. What Flu Testing Will Be Performed at MDH? This year, MDH will perform influenza testing and strain identification for surveillance only, and will only accept specimens from one patient group: Hospitalized patients with influenza-like illness (regardless of positive or negative flu test results). MDH will perform influenza testing by PCR on these specimens and determine the strain type (H3N2, H1N1, etc.) for surveillance purposes only, not for clinical care. There is a minimum turnaround time of 1-2 weeks. Which Patients Should Have Specimens Sent to MDH? All hospitalized patients with influenza-like illness (regardless of positive or negative flu test results.) 3
4 Is a Separate Specimen Required? Yes, a separate specimen must be collected for MDH. Acceptable specimens include: Nasopharyngeal swab viral transport medium (VTM) Nasopharyngeal aspirate or nasal wash in sterile container. Nasal swab in VTM (note: Although nasal swabs are acceptable for the highly sensitive PCR test performed at MDH nasal specimens are not optimal for rapid flu antigen testing) What Paperwork is Required? There is a new form this year, posted on the MDH website, to be completed by the provider and submitted with each specimen. Allina Medical Laboratories will forward the specimens and paperwork to MDH. How Long Will it Take to Get Results? This year, MDH is performing flu testing for surveillance only, not patient care. For clinical testing, there are several options available through Allina Medical Laboratories that are summarized in Table 3. Case Reporting to MDH This is different than specimen submission. The following case types need to be reported to MDH: All hospitalized Minnesota residents with laboratory confirmed influenza (including rapid testing). This will be done by Allina Medical Laboratories for positive flu test results. Any suspected influenza death or critical illness. Any unusual case incidence or cluster (including long-term care facilities). What are the Options for Clinical Testing for Patient Care? See Table 3 on page 5 for a summary of available tests and recommendations. 4
5 Table 3. Clinical Testing for Influenza Test Advantages Disadvantages Influenza A/B Antigen LAB6696 (INF) Detects and differentiates influenza A and B. See Table 2 for acceptable specimen types, which are different at the hospitals and clinics. See Table 4 for specimen collection instructions. Same day turnaround Rapid results (at the expense of accuracy). Can be helpful for ambulatory care during flu season. Proper specimen collection is essential. False positives and false negatives. Not accurate enough for patients requiring hospital admission PCR testing is preferred. Similar cost to PCR but much less sensitive or accurate. Influenza A & B by PCR LAB994 ( MSO) Viral nucleic acid detection and differentiation of influenza A & B Specimen: Rayon mini-tip swab or throat swab in viral transport medium. Nasopharyngeal aspirate or wash in sterile container. Similar cost to rapid flu testing but vastly more sensitive and accurate. Most accurate, sensitive, and specific test available. Most clinically effective test for flu detection in patients who need to be admitted to the hospital. Compliance/billing issue Can t be ordered if rapid flu testing is performed* Performed at a reference lab. 1 day turnaround Continued on Page 6 5
6 Continued from page 5 Test Advantages Disadvantages Respiratory Viral Panel by PCR LAB994 (MSO) Nucleic acid detection of influenza A/B and other respiratory viruses. Order as LAB994 Test Description: ViroMed # Specimen: NP Swab in Viral Transport Media or Nasal Wash, Nasal aspirate, BAL or Wash in Sterile Container. 1-2 day turnaround Respiratory Viral Culture LAB4724 (VRP) Specimen: NP Swab in Viral Transport Media or Nasal wash, aspirate or BAL in Sterile Container. 2-5 day turnaround H1N1 Highly sensitive and accurate for diagnosis of influenza as well as other respiratory viral infections when clinically appropriate. Detects: Influenza A Influenza B Parainfluenza 1-3 RSV Adenovirus Metapneumovirus Rhinovirus May be ordered as backup to rapid influenza testing. Detects: Influenza A Influenza B Parainfluenza 1-3 RSV Adenovirus Specific testing not indicated at present, but would be detected by PCR for influenza A. High cost (6-fold higher than rapid flu). Compliance/billing issue Can t be ordered if rapid flu testing is performed* 1-2 day turnaround time Performed at a reference lab. High cost (3-6 fold higher than rapid flu, depends on virus detected.) Performed at a reference lab. Not orderable *Influenza PCR and rapid tests are all considered antigen tests. Ordering more than one antigen test for influenza will result in payer rejections and billing compliance issues. 6
7 What precautions are needed when collecting specimens for flu testing? Droplet precautions during swab/aspirate/wash collection: A regular surgical mask, gown, and gloves should be worn. Airborne precautions during aerosol generating procedures such as bronchoscopy, sputum induction, intubation and extubation, open suctioning of airways: A fit-tested N95 mask or equivalent, gown, and gloves. Why isn t it helpful to perform rapid flu testing on patients who will be admitted to the hospital? Rapid flu testing isn t accurate enough to effectively impact inpatient management and could lead to misdiagnosis. A negative rapid flu test does not exclude influenza; therefore, a patient sick enough to be in the hospital with influenza-like illness and a negative rapid flu test would still receive empirical treatment and isolation precautions for influenza. A false positive rapid flu test could result in inappropriate treatment and delay recognition of the patient s true diagnosis. Even the best rapid flu tests (98% specificity) can have up to a 50% false positive rate, depending on prevalence of flu in the population. Molecular (PCR) testing for influenza A and B with next day turnaround provides more clinically useful results for inpatient management. What testing is recommended for inpatients? Influenza A and B detection by PCR, which has a 1-day turnaround and is performed at a reference laboratory. This is the most sensitive and accurate test available. It will detect all strains of influenza A, including H1N1. Strain typing is performed for at MDH for hospitalized patients with influenza. 7
8 Table 4. Rapid Flu A & B Specimen Collection Instructions: Observe droplet precautions: Wear protective surgical mask, gown, gloves, and protective eyewear when collecting rapid flu specimens. Nasopharyngeal Swab Use a Minitip culture swab and Bacti culturette medium or viral transport medium (VTM). 1. As the mini-tip is removed from the package, bend the wire to the shape of the nasal passage. 2. Maintain sterility of the swab. 3. Tip patient s head back and swab through the nostril into the nasopharynx. 4. Rotate the swab gently and remove. 5. If any resistance is met in the passageways, do not force the swab. Try the other nostril. If the swab cannot be passed through either nostril, it may be bent at a right angle and passed through the mouth to the nasopharynx, taking care to avoid mouth and throat contamination. 6. Place swab in culturette tube or viral transport medium. Nasopharyngeal Washing or Aspirate 1. Obtain a nasopharyngeal washing collection kit. 2. With patient in supine position, tilt head back at 70 angle. 3. Attach sterile syringe to catheter. Insert catheter into nostril and instill 2 or 3 ml normal bacteriostatic saline into one nostril and pharynx. Use the minimum amount of saline possible to avoid over-dilution of antigen in the specimen. 4. Aspirate fluid out of nostril with syringe. 5. Gently suction with syringe while withdrawing catheter. 6. Screw tip onto syringe full of solution to prevent leakage during transport or place into sterile screw top container. Transport immediately. Nasal swab (Allina Clinics only). Nasal swabs generally have a lower detection rate than NP swabs, especially in adults. 1. Obtain a special QuickVue foam nasal collection swab from the clinic laboratory. 2. It is important to obtain as much secretion as possible. 3. Insert the sterile swab into the nostril that presents the most secretion under visual inspection. 4. Using gentle rotation, push the swab until resistance is met at the level of the turbinates (less than one inch into the nostril). 5. Rotate the swab a few times against the nasal wall. For questions, comments, or suggestions about this newsletter or other laboratory issues, please contact Lauren Anthony, MD, Medical Director of Allina Medical Laboratories, (612) or Lauren.Anthony@allina.com 8
Lab Alert REMINDER: BioFire- FilmArray Respiratory Panel
Department of Pathology Laboratory Alert November 11, 2015 Lab Alert REMINDER: BioFire- FilmArray Respiratory Panel The Molecular Pathology and Microbiology Sections of the Pathology Laboratory is continuing
More informationAseptic technique for NPA collection
PTCOC Commissioned Training Infection Control for Physiotherapists (Workshop) Aseptic technique for NPA collection By Mr. Tony AU Physiotherapist, TKOH Nasopharyngeal Aspirate (NPA) Useful for diagnosis
More informationPediatric Infections caused by the Swine-Origin Influenza A (H1N1) Virus (S-OIV) 5/1/09 Update
Pediatric Infections caused by the Swine-Origin Influenza A (H1N1) Virus (S-OIV) 5/1/09 Update The Centers for Disease Control and Prevention (CDC) has confirmed the presence of a novel swine influenza
More informationInfluenza Kit Contents 2009
Influenza Kit Contents 2009 A facility flu kit will be assembled prior to the start of the influenza season to enable a timely organized community response. The kit contains the following: Influenza Swabs,
More informationGuidelines for Sample Collection and Handling of Human Clinical samples for Laboratory Diagnosis of H1N1 Influenza
Guidelines for Sample Collection and Handling of Human Clinical samples for Laboratory Diagnosis of H1N1 Influenza National Institute Of Communicable Diseases 22- Sham Nath Marg New Delhi -110054 DIRECTORATE
More informationRapid-VIDITEST. Influenza A+B
Rapid-VIDITEST Influenza A+B (One step Influenza A+B blister Test for the detection of Influenza type A and type B from nasal swabs, nasal wash or nasal aspirate specimens). Instruction manual Producer:
More informationTo: Healthcare Providers, Hospitals, Laboratories, Local Health Departments
April 29, 2009 To: Healthcare Providers, Hospitals, Laboratories, Local Health Departments From: NYSDOH Bureau of Communicable Disease Control and Wadsworth Laboratory HEALTH ADVISORY: UPDATE #2--SWINE
More informationINFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)
INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases) 1. Agent: Influenza viruses A, B, and C. Only influenza A and B are of public health concern since they are responsible for epidemics. 2. Identification:
More informationHealthcare Providers, Hospitals, Laboratories, Local Health Departments. From: NYSDOH Bureau of Communicable Disease Control and Wadsworth Laboratory
Richard F. Daines, M.D. Commissioner Wendy E. Saunders Executive Deputy Commissioner April 25, 2009 To: Healthcare Providers, Hospitals, Laboratories, Local Health Departments From: NYSDOH Bureau of Communicable
More informationInfluenza A & B Screening
Chapter 8 Influenza A & B Screening CHAPTER 8: INFLUENZA TYPE A AND B Page 1 of 6 Flu 3-5-02.doc 6/24/2005 Procedure: Nasal Swab for Influenza type A and B by Quidel influenza test PRINCIPLE: The QuickVue
More informationClinical Aspects Fever (94%), cough (92%), sore throat (66%) 25% diarrhea and 25% vomiting Around 9% requiring i hospitalization ti Age groups: only 5
Novel H1N1 Influenza June 19, 2009 CHICA Manitoba Evelyn Lo H1N1-the story In April of 2009, CDC was alerted to 2 children in California with a novel strain of H1N1 influenza At about the same time, Mexico
More informationTISSUE COLLECTION. SCPA 603- Histopathological Techniques for Routine and Research
TISSUE COLLECTION SCPA 603- Histopathological Techniques for Routine and Research Somphong Narkpinit, MD. Department of Pathobiology Faculty of Science, Mahidol University somphong.nar@mahidol.ac.th Learning
More informationRapid-VIDITEST. Influenza A
Rapid-VIDITEST Influenza A (One step Influenza A Card test for the detection of Influenza type A antigen from human nasopharyngeal specimens (swab, nasopharyngeal wash and aspirate). Instruction manual
More informationINFLUENZA-LIKE ILLNESS (ILI)
Page 1 of 5_ POLICY: Vaccination, treatment, chemoprophylaxis, and control measures will be standardized for seasonal influenza-like illness (ILI). DEFINITION: Influenza-like illness (ILI) is defined as
More informationLine Listing and Specimen Collection. Module 5
Line Listing and Specimen Collection Module 5 Learning Outcomes By the end of this module you will be able to: Explain the role of the line list in outbreak management. Identify when cases should be added.
More informationGuidance for Influenza in Long-Term Care Facilities
Guidance for Influenza in Long-Term Care Facilities DSHS Region 2/3 Epidemiology Team January 2018 1. Introduction Every year, the flu affects people around the world, regardless of age. However, residents
More informationHuman Influenza A (Swine Flu) Rapid test
Human Influenza A (Swine Flu) Rapid test Cat.No: DTSXY-Z9 Lot. No. (See product label) Size 20T Intended use The Influenza A (Swine Flu) test is a rapid chromatographic immunoassay for the qualitative
More informationDEPARTMENT OF HEALTH AND MENTAL HYGIENE. nyc.gov/health
THE CITY OF NEW YORK DEPARTMENT OF HEALTH AND MENTAL HYGIENE Michael R. Bloomberg Mayor Thomas R. Frieden, M.D., M.P.H. Commissioner nyc.gov/health 2009 New York City Department of Health and Mental Hygiene
More informationClostridium difficile Specimen Collection
Clostridium difficile Specimen Collection Collect stool specimens into a clean, airtight container with no preservative. All stool specimens should be tested as soon as possible. Ideally, stool specimens
More informationMARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE John M. Colmers, Secretary
MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE John M. Colmers, Secretary COMMUNITY HEALTH ADMINISTRATION Peter A. Sybinsky, Ph.D., Director Richard W. Stringer, Deputy Director April 29, 2009 Swine
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXVIII NUMBER 7 November/December 2013 CONTAGIOUS COMMENTS Department of Epidemiology Respiratory Season 2013 14 Kelly West MS, RN, CIC, Christine Robinson, PhD, & the Respiratory Season Planning
More informationRespiratory Pathogen Panel TEM-PCR Test Code:
Respiratory Pathogen Panel TEM-PCR Test Code: 220000 Tests in this Panel Enterovirus group Human bocavirus Human coronavirus (4 types) Human metapneumovirus Influenza A - Human influenza Influenza A -
More informationRapid-VIDITEST Swine Flu
Rapid-VIDITEST Swine Flu One Step Influenza type A Antigen Card test. Instruction manual Producer: VIDIA spol. s r.o., Nad Safinou II 365, 252 50 Vestec, Czech Republic, Tel.: +420 261 090 565, www.vidia.cz
More informationnstitute of Medicine ommittee on Implementation of Antiviral Medication trategies for an Influenza Pandemic
nstitute of Medicine ommittee on Implementation of Antiviral Medication trategies for an Influenza Pandemic iagnosis of Influenza in Children John Bradley, MD, FAAP Member, Committee on Infectious Diseases
More informationJOB A IDS for collection, storage and transport of specimens for laboratory confirmation of Middle East respiratory syndrome coronavirus (MERS-CoV)
JOB A IDS for collection, storage and transport of specimens for laboratory confirmation of Middle East respiratory syndrome coronavirus (MERS-CoV) Integrated Disease Surveillance Programme Disease Prevention
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationSwine Influenza 2009
Swine Influenza 2009 A new strain of swine influenza virus (swh1n1) Large outbreak in Mexico 1324 suspect cases 81 deaths reported (26 confirmed swh1n1) Mexico City schools closed 91 U.S. cases so far
More informationWeekly Influenza & Respiratory Activity: Statistics Summary
Weekly Influenza & Respiratory Activity: Statistics Summary 2011-12 updated 7/12/12 Influenza Activity in Minnesota Summary of the 2011-12 Season Since the start of the influenza season, 552 people were
More informationSwine Influenza Update #3. Triage, Assessment, and Care of Patients Presenting with Respiratory Symptoms
Updated 12:00 p.m. April 30, 2009 Swine Influenza Update #3 Introduction: This document revises our last update which was sent April 28 th, 2009. The most important revisions include the following: 1.
More informationProtocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel 2 plus (RP2plus)
Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel 2 plus (RP2plus) Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality
More informationWeekly Influenza Activity: Statistics Summary
Weekly Influenza Activity: Statistics Summary 2010-11 updated 9/9/11 Summary of the 2010-11 Influenza Season Since the start of the influenza season, 215 schools reported outbreaks of ILI. Influenza Activity
More informationCOLLECTION GUIDELINE FOR LABORATORY DIAGNOSIS OF COMMON VIRAL INFECTIONS
1 of 5 Policy #: Subject: 609 (PLH-609-07) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 COLLECTION GUIDELINE FOR LABORATORY DIAGNOSIS OF COMMON VIRAL INFECTIONS Approved by: Laboratory Director, Jerry
More informationHealthcare Providers, Hospitals, Laboratories, Local Health Departments. From: NYSDOH Bureau of Communicable Disease Control and Wadsworth Laboratory
Richard F. Daines, M.D. Commissioner Wendy E. Saunders Executive Deputy Commissioner April 30, 2009 To: Healthcare Providers, Hospitals, Laboratories, Local Health Departments From: NYSDOH Bureau of Communicable
More informationCDHB Infection Prevention and Control Community Liaison
Infection Prevention & Control Guidelines for the management of a respiratory outbreak in ARC / LTCF Background Elderly persons are vulnerable to significant disease including hospitalisation and death
More informationInfluenza Testing Today: Keeping Up with a Moving Target
Influenza Testing Today: Keeping Up with a Moving Target Webcast Clinical Lab Products November 19, 2015 Moderator Steve Halasey Chief Editor Clinical Lab Products Sponsor www.sekisuidiagnostics.com Speaker
More informationCLIA Waived for swab samples Non-Waived for Nasal Aspirate/Wash and swabs stored/transported in media.
CLSI PROCEDURE Product Name: Item Number: 181-36025 CLIA Waived for swab samples Non-Waived for Nasal Aspirate/Wash and swabs stored/transported in media. Institution: Prepared By: Date: Title: Accepted
More informationInfluenza Update for Iowa Long-Term Care Facilities. Iowa Department of Public Health Center for Acute Disease Epidemiology
Influenza Update for Iowa Long-Term Care Facilities Iowa Department of Public Health Center for Acute Disease Epidemiology Webinar Information All participants will be muted during the presentation. Questions
More informationMinistry of Health and Long-Term Care
Ministry of Health and Long-Term Care Guidance for Management of Patients with Influenza-like Illness in Long-Term Care Settings during the Pandemic (H1N1) 2009 Summary VERSION: 1 IHN: Issue 6, Volume
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXX NUMBER 1 January 2015 CONTAGIOUS COMMENTS Department of Epidemiology Respiratory Season 2014 15 Kellie Rusin MLS (ASCP)CM MPH, Christine Robinson PhD, James Gaensbauer MD, MScPH, & the Respiratory
More informationIMMUNOFLUORESCENT STAINING FOR RESPIRATORY VIRUS DETECTION: INFLUENZA A, INFLUENZA B AND RESPIRATORY SYNCYTIAL VIRUS
IMMUNOFLUORESCENT STAINING FOR RESPIRATORY VIRUS DETECTION: INFLUENZA A, INFLUENZA B AND RESPIRATORY SYNCYTIAL VIRUS A. Introduction Influenza A, Influenza B and RSV are responsible for serious respiratory
More informationMICROBIOLOGY SPECIMEN COLLECTION MANUAL
Lee Memorial Health System Lee County, FL CLINICAL LABORATORY MICROBIOLOGY SPECIMEN COLLECTION MANUAL ACID FAST CULTURE Specimen Type see Specimen Chart ACID FAST STAIN see Specimen Chart Acid Fast stain
More informationRESPIRATORY VIRUS SURVEILLANCE REPORT
RESPIRATORY VIRUS SURVEILLANCE REPORT Week Ending January 20, 2018 Wisconsin Department of Health Services Division of Public Health Bureau of Communicable Diseases Communicable Diseases Epidemiology Section
More informationEvidence Based Practice Presentation
Evidence Based Practice Presentation When obtaining secretions for respiratory virus screening in children are nasal swabs as effective in achieving an accurate diagnosis, or does nasal pharyngeal aspirate
More informationAppendix C. RECOMMENDATIONS FOR INFECTION CONTROL IN THE HEALTHCARE SETTING
Appendix C. RECOMMENDATIONS FOR INFECTION CONTROL IN THE HEALTHCARE SETTING Infection Control Principles for Preventing the Spread of Influenza The following infection control principles apply in any setting
More informationSeasonal Influenza Report
Key findings for the 2017 2018 flu season October 1 st, 2017 (CDC Disease Week 40) marked the beginning of the 2017 2018 influenza season. Influenza activity is increasing in California. As of November
More informationInformation collected from influenza surveillance allows public health authorities to:
OVERVIEW OF INFLUENZA SURVEILLANCE IN NEW JERSEY Influenza Surveillance Overview Surveillance for influenza requires monitoring for both influenza viruses and disease activity at the local, state, national,
More informationCDC Health Advisory 04/29/2009
H1N1 (Swine Flu) is a sub-type of Influenza A. Wexford Labs disinfectants are effective against Influenza A. Current CDC Recommendations for Environmental Control in the Healthcare Setting: CDC Health
More informationSeasonal Influenza Report
Key findings for the 2017 2018 flu season Seasonal Influenza Report 2017 2018 Influenza activity is widely circulating in California. As of week 52 (December 24 30, 2017), the statewide geographic distribution
More informationARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)
ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015) 2014-2015 Season (9/28/2014 10/3/2015) Synopsis: Influenza activity is increasing in Arizona. Arizona reported Widespread activity for week 1. Influenza
More informationDr. Cristina Gutierrez, Laboratory Director, CARPHA SARI/ARI SURVEILLANCE IN CARPHA MEMBER STATES
Dr. Cristina Gutierrez, Laboratory Director, CARPHA SARI/ARI SURVEILLANCE IN CARPHA MEMBER STATES SARI/ARI Surveillance in CARPHA Member States* Objectives of SARI Surveillance: To detect unusual or unexpected
More informationFolks: The attached information is just in from DOH. The highlights:
Folks: The attached information is just in from DOH. The highlights: ALL ILI (influenza-like illness) should be considered to be flu. It doesn't matter if it's H1N1, or some other strain. It all spreads
More informationInfluenza Laboratory Surveillance DSHS Flu Surveillance Workshop Lesley Brannan, MPH
Influenza Laboratory Surveillance 2016 DSHS Flu Surveillance Workshop Lesley Brannan, MPH Outline Submitter recruiting and specimen considerations Specimen collection and shipping Influenza testing Influenza
More informationHighlights. NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Influenza Surveillance Report Week ending January 28, 2017 (Week 4)
NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Influenza Surveillance Report Week ending January 28, 2017 (Week 4) Highlights * Influenza surveillance activities for the 2016-2017 season began on
More informationMASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019
MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019 All data in this report are preliminary and subject to change as more information is received. Sentinel Provider Surveillance:
More informationRespiratory Protection and Swine Influenza
PAGE 1 TechUpdate Respiratory Protection and Swine Influenza Frequently asked Questions The U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have recently issued
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending January
More informationSeasonal Influenza Report
Key findings for the 2017 2018 flu season Seasonal Influenza Report 2017 2018 Influenza activity remains elevated throughout California. As of 2018 week 9 (February 25 March 3, 2018), the statewide geographic
More informationInfection Prevention & Control Guidelines for the Management of Influenza and Respiratory Viral Illness
Infection Prevention & Control Guidelines for the Management of Influenza and Respiratory Viral Illness CDHB Infection Prevention & Control Service Updated May 2018 Table of Contents 1. Purpose... 3 2.
More informationSevere Acute Respiratory Infection (SARI) Guidelines. Chief Public Health Office Department of Health & Wellness
Severe Acute Respiratory Infection (SARI) Guidelines Chief Public Health Office Department of Health & Wellness 2013 The following document was prepared by the SARI Working Group. Maureen Anderson, Public
More informationPUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA
INFLUENZA DEFINITION Influenza is an acute highly infectious viral disease characterized by fever, general and respiratory tract catarrhal manifestations. Influenza has 3 Types Seasonal Influenza Avian
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending April
More informationVancouver Coastal Health-Influenza Prevention and Control Program for Residential Care Facilities
Vancouver Coastal Health-Influenza Prevention and Control Program for Residential Care Facilities Purpose Early detection and implementation of control measures are essential for the control of outbreaks
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending December
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationLaboratory Guideline for Pandemic Influenza Diagnosis at Medical Institutions
Laboratory Guideline for Pandemic Influenza Diagnosis at Medical Institutions March 26, 2007 Pandemic Influenza Experts Advisory Committee 153 Laboratory Guidelines for Pandemic Influenza Diagnosis at
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More information2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key
Name: School: Instructor: Date: 2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key For questions about this test, contact Infection Prevention and Control at 678-312-3308. 1. When do you
More informationG1 - Specimen collection
General information G1 - Specimen collection Respiratory virus diagnosis depends on the collection of high-quality specimens, their rapid transport to the laboratory and appropriate storage before laboratory
More informationRapid Detection FAQs
Rapid Detection FAQs 3M Rapid Detection Reader What are the dimensions of the Rapid Detection Reader? The Rapid Detection Reader includes the Control Module and the Test Module. The Control Module is 185
More informationWeekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
More informationInfluenza-Associated Pediatric Mortality rev Jan 2018
rev Jan 2018 Infectious Agent Influenza A, B or C virus BASIC EPIDEMIOLOGY Transmission Transmission occurs via droplet spread. After a person infected with influenza coughs, sneezes, or talks, influenza
More informationSeasonal Influenza. Provider Information Sheet. Infectious Disease Epidemiology Program
August 2007 te: This sheet contains information on seasonal influenza. For information on avian or pandemic influenza, contact the (800-423-1271 or 304-558-5358). What is influenza-like illness (ILI)?
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationModule 1 : Influenza - what is it and how do you get it?
Module 1 : Influenza - what is it and how do you get it? Responsible/facilitators General Objective Specific Objectives Methodology Agency medical coordinator Understand the mechanism how influenza is
More informationInfluenza Activity Level 3 ILI 5 Activity
Respiratory Virus Surveillance Report 1 New Jersey Department of Health Communicable Disease Service Week ending December 3, 217 (MMWR week 52 2 ) Week 4 Week 45 Week 5 Week 3 Week 8 Week 13 Week 18 Week
More informationThe Application of molecular POCT for Influenza and Group A Strep Detection
The Application of molecular POCT for Influenza and Group A Strep Detection Gregory J. Berry, Ph.D., D(ABMM) Assistant Professor, Pathology and Laboratory Medicine Zucker School of Medicine at Hofstra/Northwell
More informationInfluenza Weekly Surveillance Bulletin
Influenza ly Surveillance Bulletin Northern Ireland, (11-17 December ) Summary All indicators of influenza virus activity have increased. GP consultation rates for combined flu/ FLI increased from 28.1/,
More informationLong Term Care Respiratory Outbreak Worksheet Edmonton Zone
Long Term Care Respiratory Outbreak Worksheet Edmonton Zone Page 1 This worksheet is provided as an optional tool for use during respiratory outbreaks in Long Term Care facilities in Edmonton Zone. This
More informationANNEX I: INFECTION CONTROL GUIDELINES FOR PANDEMIC INFLUENZA MANAGEMENT
ANNEX I: INFECTION CONTROL GUIDELINES FOR PANDEMIC INFLUENZA MANAGEMENT During an influenza pandemic, adherence to infection control practices is extremely important to prevent transmission of influenza.
More informationInfluenza: Wrap- Up and Preview of the Upcoming Season. October 6, 2016 Anita Valiani, MPH
Influenza: 2015-2016 Wrap- Up and Preview of the Upcoming Season October 6, 2016 Anita Valiani, MPH Anita.valiani@dhhs.nc.gov NC SHARPPS Surveillance for Healthcare-Associated Infections and Resistant
More informationInfluenza Activity Level 3 ILI 5 Activity
Respiratory Virus Surveillance Report 1 New Jersey Department of Health Communicable Disease Service Week ending February 1, 218 (MMWR week 6 2 ) Week 4 Week 45 Week 5 Week 3 Week 8 Week 13 Week 18 Week
More informationTable 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component
Texas Surveillance Report 2017 2018 Season/2018 MMWR Week 03 (Jan. 14, 2018 Jan. 20, 2018) Report produced on 1/27/2018 Summary activity remains high across the state of Texas. Compared to the previous
More informationInfectious Disease Diagnostics in the Geisinger Health System
10X Essentials Infectious Disease Diagnostics in the Geisinger Health System NEW: Rapid GeneXpert PCR NEW Test Codes: MRSAP, MRSA Screen PCR CDIFP, C. difficile/ Epi PCR EVP, Enterovirus PCR Specimens
More informationSeasonal Influenza Report
Seasonal Influenza Report 218 219 CDC Disease Week 45 (November 4 November 1, 218) Updated November 13, 218 Key findings for the 218 219 flu season Current Week (Week 45) Current Season Summary November
More informationSwine Flu. Background. Interim Recommendations. Infectious Period. Case Definitions for Infection with Swine-origin
Page 1 of 5 Swine Flu Interim Guidance for Emergency Medical Services (EMS) Systems and 9-1-1 Public Safety Answering Points (PSAPs) for Management of Patients with Confirmed or Suspected Swine- Origin
More informationFLU REVIEW. Week 1: December 31, 2017-January 6, 2018
Florida FLU REVIEW : December, 7-January, Summary State influenza and influenza-like illness (ILI) activity: Flu season is well underway with steady and sharp increases in activity over the past several
More informationHEALTH ADVISORY Mumps outbreaks in Colorado Feb. 8, Key points. Health care providers: Please distribute widely in your office
HEALTH ALERT NETWORK BROADCAST MESSAGE ID: 02082019 14:30 FROM: CO-CDPHE SUBJECT: HAN Advisory Mumps outbreaks in Colorado RECIPIENTS: Local Public Health Agencies / IPs / Clinical Labs / EDs / ID Physicians
More informationAlkaline Phosphatase, Bone Specific
Alkaline Phosphatase, Bone Specific Order Name: ALK P BONE Test Number: 3656500 REV DATE:11/5/2010 Alkaline Phosphatase, Bone Specific IMMENZ Preferred 1 ml (0.3) Serum Clot Activator SST (Red/Gray or
More informationSwine Flu; Symptoms, Precautions & Treatments
Swine Flu; Symptoms, Precautions & Treatments What is the swine flu? Swine flu, also known as the H1N1 virus, is a relatively new strain of an influenza virus that causes symptoms similar to the regular
More informationSurveillance of influenza in Northern Ireland
Surveillance of influenza in Northern Ireland 2011-2012 Summary: The influenza season started later than normal, clinical indices began to increase marginally in mid-february, much later than previous
More informationWeekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
More informationNext report date: May 27 (May 8 21)
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 17 & 18 (Apr.24 May 7, 216) Data extracted May 13, 216 at 11: am Next report date:
More informationSummary: Low activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 43 (Oct.22 28, 2017) Data extracted Nov.3, 2017 at 11:00 am Summary: Low
More informationTarrant County Influenza Surveillance Weekly Report CDC Week 20: May 11-17, 2014
Tarrant County Public Health Division of Epidemiology and Health Information Tarrant County Influenza Surveillance Weekly Report 20: May 11-17, 2014 Influenza Activity Code, County and State Levels Tarrant
More informationH1N1: Pediatric Surge Capacity Strategies and Lessons Learned
H1N1: Pediatric Surge Capacity Strategies and Lessons Learned Daniel B. Fagbuyi, MD, FAAP MAJ, MC, USAR Medical Director, Disaster Preparedness and Emergency Management Children s s National Medical Center,
More informationPandemic Flu: Non-pharmaceutical Public Health Interventions. Denise Cardo,, M.D. Director Division of Healthcare Quality Promotion
Pandemic Flu: Non-pharmaceutical Public Health Interventions Denise Cardo,, M.D. Director Division of Healthcare Quality Promotion Pandemic Influenza Planning Challenges Cannot predict from where or when
More informationMinnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending October
More information